Epigallocatechin 3-gallate (EGCG), an abundant polyphenolic component derived from
green tea extract, possesses versatile bioactivities that can combat many diseases. During …

Parkinson's disease (PD) is the second most common neurodegenerative disease, with
symptoms such as tremor, bradykinesia with rigidity, and depression appearing in the late …

Recent studies have demonstrated that disturbances in the gut microbiota and microbiota-
derived metabolites contribute to the pathogenesis of Parkinson's disease (PD), suggesting …

A growing body of evidence suggests that the gut microbiota contributes to the development
of neurodegenerative diseases via the microbiota-gut-brain axis. As a contributing factor …

Since the description of some peculiar symptoms by James Parkinson in 1817, attempts
have been made to define its cause or at least to enlighten the pathology of “Parkinson's …

Neuroinflammation is a pathological mechanism contributing to neurodegenerative
diseases. For in-depth studies of neuroinflammation, several animal models reported …

There is a pressing need for disease-modifying therapies in patients suffering from
neurodegenerative diseases, including Parkinson's disease (PD). However, these disorders …

Background Quantitative electroencephalography (QEEG) is a reliable and non-invasive
diagnostic tool to quantify cortical synaptic injury or loss in the clinical assessment of …

Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by
numerous motor and non-motor symptoms. Recent data highlight a potential interplay …

An altered immune response has been identified as a pathophysiological factor in
Parkinson's disease (PD). We aimed to identify blood immunity-associated proteins that …